Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

3.0K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
3.0K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.6K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.6K
Antibody Actions01:26

Antibody Actions

1.5K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.5K
Antimicrobial Proteins01:23

Antimicrobial Proteins

8.1K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
Same author

Corrigendum: Locally relevant, ethically urgent: Defending SASOP's stance on transgender and non-binary youth.

The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa·2026
Same author

Nanotube vesicles: a new neutrophil inflammatory response.

Blood·2026
Same author

The introduction of workplace-based assessment into postgraduate medical training in South Africa: trainee perspectives.

BMC medical education·2026
Same author

Locally relevant, ethically urgent: Defending SASOP's stance on transgender and non-binary youth.

The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa·2026
Same author

Functional characterisation of Target of Rapamycin (TOR) signalling in Physcomitrella.

Plant cell reports·2026

Related Experiment Video

Updated: Oct 2, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.2K

A synthetic protein as efficient multitarget regulator against complement over-activation.

Natalia Ruiz-Molina1, Juliana Parsons1, Madeleine Müller1

  • 1Plant Biotechnology, Faculty of Biology, University of Freiburg, Freiburg, Germany.

Communications Biology
|February 23, 2022
PubMed
Summary
This summary is machine-generated.

A novel engineered protein, MFHR13, effectively regulates the complement system, offering a potential therapeutic for complement-associated diseases. This synthetic protein demonstrates superior activity compared to existing treatments.

More Related Videos

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

7.0K
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.8K

Related Experiment Videos

Last Updated: Oct 2, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.2K
Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

7.0K
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.8K

Area of Science:

  • Immunology
  • Biochemistry
  • Protein Engineering

Background:

  • The complement system is crucial for innate immunity but its dysregulation causes disease.
  • Factor H (FH) regulates complement activation but is not readily available therapeutically.
  • Engineered proteins offer potential alternative complement-targeting therapies.

Purpose of the Study:

  • To design and characterize a novel synthetic protein, MFHR13, for complement system regulation.
  • To evaluate MFHR13's therapeutic potential for complement-associated diseases.

Main Methods:

  • Protein engineering to create a fusion protein (MFHR13) combining domains from FH and FHR1.
  • Assessing MFHR13's complement regulatory activity using sheep erythrocytes.
  • Investigating the binding of MFHR13 and FHR1 to membrane attack complex proteins.

Main Results:

  • MFHR13 demonstrated significantly higher regulatory activity than eculizumab and human FH.
  • MFHR13 exhibits 26-fold and 4-fold greater activity than eculizumab and human FH, respectively.
  • MFHR13 and FHR1 bind to all membrane attack complex proteins, elucidating FHR1's mechanism.

Conclusions:

  • MFHR13 is a potent, multitarget complement regulator.
  • MFHR13 shows promise as a therapeutic candidate for complement-mediated diseases.
  • Understanding FHR1's interaction with the membrane attack complex is enhanced by these findings.